Featured Research

from universities, journals, and other organizations

Studies Find Possible Drug Targets For Improving Vascular Health

Date:
August 29, 2005
Source:
Yale University
Summary:
The enzyme nitric oxide synthase plays a role in peripheral vascular disease, a common disease that impairs the mobility of 25 percent of people over the age of 50.

New Haven, Conn.-The enzyme nitric oxide synthase plays a role inperipheral vascular disease, a common disease that impairs the mobilityof 25 percent of people over the age of 50, according to a Yale studyin the Proceedings of the National Academy of Sciences (PNAS).

In a related study this month in the Journal of ClinicalInvestigation, the same investigator, William Sessa, professor ofpharmacology at Yale School of Medicine, found that the protein kinase,Akt1, one of three Akt molecules involved in growth, survival,metabolism and other cellular functions, is responsible for enhancingnew blood vessel growth following a blockage due to ischemia.

In the PNAS study Sessa used mice missing the endothelialnitric oxide synthase gene and found they had impaired ability to buildarteries and capillaries, which are important for providing blood flowto muscle upon exercise training. Sessa and his colleagues alsosucceeded in using gene therapy to reverse the effects of the missinggene, which rescued limbs in danger of dying because of ischemia.Ischemia is a severe reduction of blood flow and nutrients, usuallybecause of a blood clot or atherosclerosis.

Sessa said the study in PNAS implies that therapeuticapproaches to improve blood flow and arteriogenesis in patients withperipheral vascular disease by using a single cytokine will havelimited utility unless impairments in the enzyme nitric oxide functionare taken into account and corrected.

His study on the Akt1 molecule is believed to provide thefirst direct evidence that changes in capillary formation and vascularleakage induced by the angiogenic factor vascular endothelial growthfactor (VEGF) requires Akt1. VEGF is produced by ischemic tissue, aswell as tumor cells, to stimulate the formation of new blood vessels.The data also suggest that inhibition of Akt1 signaling may be aneffective strategy to block not only tumor growth, but the pathologicalgrowth of new blood vessels from existing blood vessels that aremediated by vascular endothelial growth factor. However, Sessa said,this strategy may be a "double-edged sword" since inhibition of Akt mayalso worsen peripheral vascular disease secondary to atherosclerosis,diabetes or aging. The studies in PNAS and JCI are synergistic sinceAkt can regulate nitric oxide synthase function by increasing itsactivity.

###

PNAS 102: 10999-11004
The Journal of Clinical Investigation 115: 2119-2127


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Studies Find Possible Drug Targets For Improving Vascular Health." ScienceDaily. ScienceDaily, 29 August 2005. <www.sciencedaily.com/releases/2005/08/050826075658.htm>.
Yale University. (2005, August 29). Studies Find Possible Drug Targets For Improving Vascular Health. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2005/08/050826075658.htm
Yale University. "Studies Find Possible Drug Targets For Improving Vascular Health." ScienceDaily. www.sciencedaily.com/releases/2005/08/050826075658.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins